×
About 2,223 results

ALLMedicine™ Antinuclear Antibody Center

Research & Reviews  682 results

Spontaneous tendon rupture in a patient with systemic sclerosis: a case report.
https://doi.org/10.1186/s12891-022-05967-6
BMC Musculoskeletal Disorders; Lin C, Shen J et. al.

Nov 25th, 2022 - Systemic sclerosis (SSc) is an incurable autoimmune disease characterized by progressive skin fibrosis and organ failure. Tenosynovitis is a common musculoskeletal manifestation, but tendon rupture has seldom reported in SSc. We present a rare cas...

Juvenile localized scleroderma: a single-center experience from India.
https://doi.org/10.1111/jdv.18765
Journal of the European Academy of Dermatology and Venere... Jindal AK, Handa S et. al.

Nov 23rd, 2022 - Juvenile localized scleroderma or morphea, a rare chronic autoimmune disease predominantly affects skin, subcutaneous tissue, and occasionally the adjacent muscle, fascia, and bone. We report the largest single centre cohort of patients with JLS f...

Kikuchi-Fujimoto disease as the initial manifestation of systemic lupus erythematosus c...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682638
BMC Pediatrics; Liu C, Jin Y et. al.

Nov 23rd, 2022 - Kikuchi-Fujimoto disease (KFD) is a self-limiting and benign disease characterized by cervical lymphadenopathy and fever. Although KFD should be made differentially diagnosed from infectious, autoimmune, and malignant diseases, it sometimes occurs...

Chronic hepatitis E in an elderly immunocompetent patient who achieved a sustained viro...
https://doi.org/10.1007/s12328-022-01733-2
Clinical Journal of Gastroenterology; Takakusagi S, Takagi H et. al.

Nov 21st, 2022 - A woman in her late 70 s was diagnosed with liver injury at a health examination. Despite treatment with ursodeoxycholic acid at a nearby hospital, her transaminase levels elevated in two peaks. She was transferred to our hospital 77 days after th...

A case of Bartonellosis mimicking systemic lupus erythematosus.
https://doi.org/10.1177/11206721221137163
European Journal of Ophthalmology; Kara M, Ozdemir GN et. al.

Nov 9th, 2022 - Cat-scratch disease (CSD) is a systemic bacterial infection caused by Bartonella henselae. The disease is typically characterized by regional lymphadenopathy developing after scratches from domestic or feral cats. Rarely, systemic involvement may ...

see more →

Drugs  11 results see all →

Clinicaltrials.gov  14 results

Immunization With NY-ESO-1 Protein Combined With CpG 7909 in Patients With Prostate Cancer
https://clinicaltrials.gov/ct2/show/NCT00292045

Oct 10th, 2022 - Eligible patients received vaccinations consisting of the NY-ESO-1 protein (100 µg) combined with CpG 7909 (2.5 mg) administered intradermally every 3 weeks for 4 doses. Patients who demonstrated stable disease, minor response, partial response, o...

Avatrombopag in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies
https://clinicaltrials.gov/ct2/show/NCT04993885

Jul 19th, 2022 - This prospective, open-label, single-center, one-arm clinical trial aims at evaluating the efficacy and safety of avatrombopag in Chinese adult ITP patients with autoantibodies fail (due to intolerance or resistance) to eltrombopag or herombopag t...

A Study of Baricitinib (LY3009104) in Participants From 2 Years to Less Than 18 Years Old With Active JIA-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis
https://clinicaltrials.gov/ct2/show/NCT04088409

Jun 23rd, 2022 - The reason for this study is to see if the study drug baricitinib given orally is safe and effective in participants with active juvenile idiopathic arthritis (JIA)-associated uveitis or chronic anterior antinuclear antibody-positive uveitis from ...

Phase 2, Open-label, Study of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-line Therapy
https://clinicaltrials.gov/ct2/show/NCT02317627

May 26th, 2022 - Study KD025-206 was a phase 2, open-label, dose-finding, safety, tolerability, activity, and PK study of KD025 in subjects with psoriasis who had failed at least 1 line of systemic therapy or phototherapy. Subjects received KD025 PO for 12 weeks. ...

Eltrombopag Combined With Low-dose Rituximab in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies
https://clinicaltrials.gov/ct2/show/NCT04915482

May 11th, 2022 - This is a prospective, open-label, nonrandomized, multicenter clinical trial aiming at comparing the efficacy and safety of combined use of eltrombopag with low-dose rituximab vs. the best available therapy(BAT)in adult immune thrombocytopenia (...

see more →

News  174 results

Elbow tenderness and swollen joints
https://www.mdedge.com/psoriatic-arthritis-challenge-center/article/257978/psoriatic-arthritis/elbow-tenderness-and-swollen

Sep 19th, 2022 - The diagnosis for this case is psoriatic arthritis (PsA). The 2018 American College of Rheumatology/National Psoriasis Foundation guidelines offer current treatment recommendations for this condition.

Scattered Flesh-Colored Papules in a Linear Array in the Setting of Diffuse Skin Thickening
https://www.mdedge.com/dermatology/article/257482/dermatopathology/scattered-flesh-colored-papules-linear-array-setting
Catherine Grace P. Hobayan, BS, Madison Grinnell, MD et. al.

Aug 31st, 2022 - The Diagnosis: Scleromyxedema A punch biopsy of the upper back performed at an outside institution revealed increased histiocytes and abundant interstitial mucin confined to the papillary dermis (Figures 1 and 2), consistent with the lichen myxede.

Multiple Eruptive Dermatofibromas Associated With Down Syndrome
https://www.mdedge.com/dermatology/article/257306/mixed-topics/multiple-eruptive-dermatofibromas-associated-down-syndrome
Timothy J. Zimmerman, MD, Saira J. George, MD

Aug 24th, 2022 - To the Editor: Dermatofibromas (also known as fibrous histiocytomas) are benign fibrous nodules that most often arise as solitary lesions on the lower extremities. Multiple eruptive dermatofibromas (MEDFs) are uncommon and have been defined as mor.

Tumor Necrosis Factor α Inhibitor–Induced Lupuslike Syndrome in a Patient Prescribed Certolizumab Pegol
https://www.mdedge.com/dermatology/article/255803/dermatopathology/tumor-necrosis-factor-inhibitor-induced-lupuslike
David Walton Crasto Jr, DO, Loren Touma, DO et. al.

Jun 28th, 2022 - To the Editor: Tumor necrosis factor α (TNF-α) inhibitor–induced lupuslike syndrome (TAILS) is a newly described entity that refers to the onset of subacute cutaneous lupus erythematosus (SCLE) during drug therapy with TNF-α antagonists. The condi.

New Blood Tests Approved for Lupus, Systemic Sclerosis Diagnoses
https://www.medscape.com/viewarticle/975837

Jun 17th, 2022 - The Food and Drug Administration has approved a new diagnostic blood test to detect monospecific Ribosomal P antibodies to support a diagnosis of systemic lupus erythematosus (SLE), particularly for people who are antinuclear antibody-negative, ac...

see more →

Patient Education  8 results see all →